John Jiang

1.6k total citations
32 papers, 1.1k citations indexed

About

John Jiang is a scholar working on Anesthesiology and Pain Medicine, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, John Jiang has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Anesthesiology and Pain Medicine, 9 papers in Surgery and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in John Jiang's work include Pain Management and Opioid Use (13 papers), Anesthesia and Pain Management (8 papers) and Opioid Use Disorder Treatment (6 papers). John Jiang is often cited by papers focused on Pain Management and Opioid Use (13 papers), Anesthesia and Pain Management (8 papers) and Opioid Use Disorder Treatment (6 papers). John Jiang collaborates with scholars based in United States, Türkiye and Netherlands. John Jiang's co-authors include G. Rhys Williams, Greg Samsa, David B. Matchar, Mona Darwish, Philmore Robertson, Mary Kirby, William Tracewell, Laurence L. Greenhill, Joseph Biederman and Craig Q. Earl and has published in prestigious journals such as Gastroenterology, Neurology and PEDIATRICS.

In The Last Decade

John Jiang

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Jiang United States	16	259	254	223	214	207	32	1.1k
Ernil Hansen Germany	19	152 0.6×	162 0.6×	267 1.2×	130 0.6×	258 1.2×	76	1.4k
Gordon Irving United States	21	90 0.3×	336 1.3×	127 0.6×	159 0.7×	308 1.5×	52	1.8k
Eli Alon Switzerland	20	111 0.4×	390 1.5×	102 0.5×	173 0.8×	654 3.2×	64	1.3k
Karen H Simpson United Kingdom	22	61 0.2×	695 2.7×	136 0.6×	239 1.1×	595 2.9×	63	1.7k
Rafael Gálvez Spain	21	75 0.3×	518 2.0×	224 1.0×	232 1.1×	241 1.2×	67	1.6k
Andrey V. Bortsov United States	24	107 0.4×	157 0.6×	243 1.1×	231 1.1×	241 1.2×	63	1.6k
Eiichi Inada Japan	20	88 0.3×	179 0.7×	128 0.6×	60 0.3×	357 1.7×	117	1.2k
Bruce M Smoller United States	7	158 0.6×	404 1.6×	174 0.8×	156 0.7×	254 1.2×	15	2.1k
Joanne Muir United States	9	73 0.3×	232 0.9×	184 0.8×	93 0.4×	154 0.7×	11	1.4k
Winston C. V. Parris United States	17	51 0.2×	287 1.1×	149 0.7×	191 0.9×	209 1.0×	64	1.1k

Countries citing papers authored by John Jiang

Since Specialization

Citations

This map shows the geographic impact of John Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Jiang more than expected).

Fields of papers citing papers by John Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Jiang. The network helps show where John Jiang may publish in the future.

Co-authorship network of co-authors of John Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of John Jiang. A scholar is included among the top collaborators of John Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Jiang. John Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Emily, Şefik Evren Erdener, John Jiang, et al.. (2025). Capillaries susceptible to frequent stall dynamics revealed by comparing OCT and bessel-2PM measurements. Journal of Cerebral Blood Flow & Metabolism. 45(10). 1905–1917.

Voermans, Nicol C., et al.. (2024). An open-label pilot study of losmapimod to evaluate the safety, tolerability, and changes in biomarker and clinical outcome assessments in participants with facioscapulohumeral muscular dystrophy type 1. Journal of the Neurological Sciences. 462. 123096–123096. 5 indexed citations

Han, Jay J., et al.. (2023). Design of REACH: Phase 3 Randomized, Double-Blind, Placebo-Controlled, 48-Week Study of the Efficacy and Safety of Losmapimod in FSHD (P6-8.007). Neurology. 100(17_supplement_2). 1 indexed citations

Wang, Leo, et al.. (2023). Results from 96 Weeks Open-Label Extension of a Phase 2 Trial of Losmapimod in Subjects with FSHD: ReDUX4 (S48.008). Neurology. 100(17_supplement_2). 1 indexed citations

Mellion, Michelle, Markus Karlsson, André Ahlgren, et al.. (2022). Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI. Neurology. 99(9). e877–e889. 18 indexed citations

Sunil, Smrithi, Şefik Evren Erdener, Xiaojun Cheng, et al.. (2020). Stroke core revealed by tissue scattering using spatial frequency domain imaging. NeuroImage Clinical. 29. 102539–102539. 8 indexed citations

McColley, Susanna A., Michael W. Konstan, Bonnie W. Ramsey, et al.. (2018). Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1. Journal of Cystic Fibrosis. 18(1). 94–101. 33 indexed citations

Kelly, Ciarán P., P. H. R. Green, Joseph A. Murray, et al.. (2012). Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo‐controlled study. Alimentary Pharmacology & Therapeutics. 37(2). 252–262. 155 indexed citations

Kelly, Ciarán P., Peter H. Green, Joseph A. Murray, et al.. (2009). M2048 Safety, Tolerability and Effects On Intestinal Permeability of Larazotide Acetate in Celiac Disease: Results of a Phase IIB 6-Week Gluten-Challenge Clinical Trial. Gastroenterology. 136(5). A–474. 14 indexed citations

10.

Darwish, Mona, et al.. (2008). Relative Bioavailability of Fentanyl Following Various Dosing Regimens of Fentanyl Buccal Tablet in Healthy Japanese Volunteers. PubMed. 1(2). 56–62. 2 indexed citations

11.

Souppart, C., Qinqin Yin, Martin Merz, et al.. (2008). Bioequivalence of oxcarbazepine oral suspension vs. film-coated tablet in healthy Chinese male subjects. International Journal of Clinical Pharmacology and Therapeutics. 46(10). 538–544. 2 indexed citations

12.

Darwish, Mona, et al.. (2008). Extent of Fentanyl Accumulation Following Multiple Doses of Fentanyl Buccal Tablet 400 µg in Healthy Japanese Volunteers. PubMed. 1(2). 50–55. 3 indexed citations

13.

Darwish, Mona, Mary Kirby, Philmore Robertson, William Tracewell, & John Jiang. (2007). Absolute and Relative Bioavailability of Fentanyl Buccal Tablet and Oral Transmucosal Fentanyl Citrate. The Journal of Clinical Pharmacology. 47(3). 343–350. 77 indexed citations

14.

Darwish, Mona, Mary Kirby, John Jiang, William Tracewell, & Philmore Robertson. (2007). Bioequivalence Following Buccal and??Sublingual Placement of Fentanyl??Buccal Tablet 400????g in??Healthy Subjects. Clinical Drug Investigation. 28(1). 1–7. 21 indexed citations

15.

Swanson, James M., Laurence L. Greenhill, Frank A. López, et al.. (2006). Modafinil Film-Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. The Journal of Clinical Psychiatry. 67(1). 137–147. 81 indexed citations

16.

Darwish, Mona, Mary Kirby, Philmore Robertson, Edward T. Hellriegel, & John Jiang. (2006). Single‐Dose and Steady‐State Pharmacokinetics of Fentanyl Buccal Tablet in Healthy Volunteers. The Journal of Clinical Pharmacology. 47(1). 56–63. 30 indexed citations

17.

Greenhill, Laurence L., Joseph Biederman, Samuel W. Boellner, et al.. (2006). A Randomized, Double-Blind, Placebo-Controlled Study of Modafinil Film-Coated Tablets in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 45(5). 503–511. 68 indexed citations

18.

Darwish, Mona, Mary Kirby, Philmore Robertson, William Tracewell, & John Jiang. (2006). Pharmacokinetic properties of fentanyl effervescent buccal tablets: A phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 μg in healthy adult volunteers. Clinical Therapeutics. 28(5). 707–714. 36 indexed citations

19.

Biederman, Joseph, James M. Swanson, Sharon B. Wigal, et al.. (2005). Efficacy and Safety of Modafinil Film–Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study. PEDIATRICS. 116(6). e777–e784. 98 indexed citations

20.

Palangio, Mark, et al.. (2000). Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of postoperative obstetric or gynecologic pain. Clinical Therapeutics. 22(5). 600–612. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact